Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors

J.A.M. Christiaans; P.J. Klein; A. Metaxas; E.J.M. Kooijman; R.C. Schuit; J.E. Leysen; A.A. Lammertsma; B.N.M. van Berckel; A.D. Windhorst

doi:10.1016/j.nucmedbio.2014.04.131

Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors

J.A.M. Christiaans, P.J. Klein, A. Metaxas, E.J.M. Kooijman, R.C. Schuit, J.E. Leysen, A.A. Lammertsma, B.N.M. van Berckel, A.D. Windhorst

Radiology and nuclear medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	670-680
Journal	Nuclear Medicine and Biology
Volume	41
Issue number	8
DOIs	https://doi.org/10.1016/j.nucmedbio.2014.04.131
Publication status	Published - 2014

Access to Document

10.1016/j.nucmedbio.2014.04.131

Cite this

Christiaans, J. A. M., Klein, P. J., Metaxas, A., Kooijman, E. J. M., Schuit, R. C., Leysen, J. E., Lammertsma, A. A., van Berckel, B. N. M., & Windhorst, A. D. (2014). Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors. Nuclear Medicine and Biology, 41(8), 670-680. https://doi.org/10.1016/j.nucmedbio.2014.04.131

@article{8e9f3353467f4db5a160e1de81765fb4,

title = "Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors",

author = "J.A.M. Christiaans and P.J. Klein and A. Metaxas and E.J.M. Kooijman and R.C. Schuit and J.E. Leysen and A.A. Lammertsma and {van Berckel}, B.N.M. and A.D. Windhorst",

year = "2014",

doi = "10.1016/j.nucmedbio.2014.04.131",

language = "Undefined/Unknown",

volume = "41",

pages = "670--680",

journal = "Nuclear Medicine and Biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "8",

}

Christiaans, JAM, Klein, PJ, Metaxas, A, Kooijman, EJM, Schuit, RC, Leysen, JE, Lammertsma, AA , van Berckel, BNM & Windhorst, AD 2014, 'Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors', Nuclear Medicine and Biology, vol. 41, no. 8, pp. 670-680. https://doi.org/10.1016/j.nucmedbio.2014.04.131

Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors. / Christiaans, J.A.M.; Klein, P.J.; Metaxas, A. et al.

In: Nuclear Medicine and Biology, Vol. 41, No. 8, 2014, p. 670-680.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Synthesis and preclinical evaluation of carbon-11 labelled N-((5-(4-fluoro-2-[C-11]methoxyphenyl) pyridin-3-yl) methyl) cyclopentanamine as a PET tracer for NR2B subunit-containing NMDA receptors

AU - Christiaans, J.A.M.

AU - Klein, P.J.

AU - Metaxas, A.

AU - Kooijman, E.J.M.

AU - Schuit, R.C.

AU - Leysen, J.E.

AU - Lammertsma, A.A.

AU - van Berckel, B.N.M.

AU - Windhorst, A.D.

PY - 2014

Y1 - 2014

U2 - 10.1016/j.nucmedbio.2014.04.131

DO - 10.1016/j.nucmedbio.2014.04.131

M3 - Article

C2 - 24929961

VL - 41

SP - 670

EP - 680

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 8

ER -